Treatment of Corneal Neovascularization With Topical Pazopanib

NCT01257750 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Reza Dana, MD